LAS VEGAS, July 26, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. HYEX , a leading innovator of clinically proven plant-based products for heart and brain health, has launched a prospective, investigational trial to study the effect of its UBN ACTIVATE™ on golf performance.
The study will investigate if the natural brain activation supplement can improve golfers' energy conservation, mental focus and score during each round.
During play, 10 subjects will wear metabolic measurement equipment to evaluate on-course energy expenditure. They will then play nine holes of golf with and without taking ACTIVATE, and rate their overall focus, tee shots, second shots and short game accordingly. Each subject will also be evaluated with their preferred mode of golf transport: pushcart, electric trolley or motor cart.
Neil Wolkodoff, PhD, medical program director of the Colorado Center for Health and Sports Science, will be the lead investigator for the study. An avid golfer, he has authored several books about the physiology of the sport, including Physical Golf and Core Powered Golf.
According to Dr. Wolkodoff, this is the first energy expenditure study of golf that will correlate mental focus to scores.
The study is sponsored by the Colorado Center for Health & Sports Science and the Colorado Golf Association, with the testing conducted at the Common Ground Golf Course in Aurora, Colorado. The study is expected to conclude in October, with the result to be published in a peer-reviewed, scientific journal.
The study is expected to build upon the success of a randomized, placebo-controlled clinical trial published in Annals of Reviews and Research that highlighted the ability of ACTIVATE to naturally increase key brain activity by as much as 46%.
Clinical studies have shown ACTIVATE dramatically improves human cognitive behavior and mental focus by activating areas of the brain primarily responsible for attention, memory, mood, and reaction times. These benefits are a result of the company's KETONOMICS® proprietary formulations clinically shown to quickly generate strong and sustained ketone levels in the brain.
Duke Pitts, president of Healthy Extracts, stated: "We anticipate significant results from this observational trial of the effect of ACTIVATE on golf performance. We've received preliminary positive indications, including anecdotal reports from users stating that their golf game improved substantially. We're now looking forward to this study to provide actual results that will confirm these observations."
According to Rich "The G-man" Goins, noted radio sportscaster and ACTIVATE user: "I attribute some of my best golf rounds in the last six months to taking UBN ACTIVATE. I'm definitely more focused and calm while putting, and have the mental edge in making shots that help me score and win tournaments."
Added Pitts: "Looking at our sales channels, we see many B2B opportunities with major golf companies that would be interested in an all-natural supplement that could provide golfers an edge in their game. We also anticipate attracting golfers under our brand influencer program, where we can secure key product endorsements."
The company plans to launch additional clinical trials studying ACTIVATE's effect on athletes in other sports, such as martial arts.
About UBN ACTIVATE UBN ACTIVATE is a specialized version of Healthy Extracts' proprietary, patent-protected formulations. The company's unique products are the result of more than 20 years of scientific research, including multiple clinical studies on the key ingredients.
The ingredients are naturally derived and contain no caffeine or added sugar, and its powerful brain activation benefits have been shown to last eight hours or more.
The formulation also contains a proprietary blend of other effective ingredients, including a naturally sourced spearmint extract that has been clinically shown to support mental focus during the day without disrupting sleep at night and a protective free radical scavenger found naturally in the body that helps the brain function optimally, while promoting a healthy mood and supporting healthy sleep habits.
It also includes a unique natural marigold extract that is scientifically shown to block blue light, enhance brain carotenoid antioxidant levels and replenish lutein, which is critical for optimum eye health.
Healthy Extracts' product research and development is focused on the brain health supplement market that is expected to grow at an 8% compounded annual growth rate (CAGR) to reach $15.7 billion by 2030.
To learn more about ACTIVATE and Healthy Extracts' other products, go to tryubn.com and bergametna.com.
About Healthy Extracts "Live Life Young Again" Healthy Extracts Inc. is a platform for developing or acquiring science-forward, clinically proven, plant-based proprietary products in select high-growth categories within the multibillion-dollar nutraceuticals market.
The company's subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with healthy heart benefits backed by more than 17 clinical studies.
UBN KETONOMICS® proprietary formulations have been clinically shown to support brain health, including memory, cognition, focus and neuro-energy. UBN is pursuing intellectual property license opportunities for monetizing its IP portfolio of multiple issued and pending patents.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2022, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food and Drug Administration Disclosure
The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor's advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™
Healthy Extracts Company Contact Duke Pitts, President Healthy Extracts Inc. Tel (720) 463-1004 Email contact
Investor & Media Contact Ronald Both or Justin Lumley CMA Investor & Media Relations Tel (949) 432-7566 Email contact Media Contact: Tim Randall CMA Tel (949) 432-7572 Email Contact
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/805c9c95-2ea2-42b0-9d38-6024ad2ecbaa
https://www.globenewswire.com/NewsRoom/AttachmentNg/aa9f00d5-2b75-4891-b473-9eaa174d4a05
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.